started · updated
Incheon Sejong Hospital reaches 50 Left Ventricular Assist Device implantations
Incheon Sejong Hospital has announced the successful completion of 50 Left Ventricular Assist Device (LVAD) implantations, marking a significant milestone in the treatment of end-stage heart failure. The hospital is the third in South Korea to reach this figure and the only general hospital to do so.
LVAD is an implantable medical device used to assist blood circulation in patients with severely diminished heart function. It serves as a bridge to survival for those awaiting heart transplants or as a long-term treatment option depending on the patient's condition. Since first applying the third-generation HeartMate 3 (HM3) in 2021, the hospital has established a comprehensive management system covering pre-operative evaluation, intensive care, and post-discharge follow-up.
The hospital reported maintaining a 0% mortality rate following these procedures and has also implemented bloodless LVAD implantations. The success is attributed to a multidisciplinary approach involving cardiology, cardiovascular surgery, intensive care, infectious diseases, rehabilitation, and pharmacy teams.
Entities
HeartMate 3 · Incheon Sejong Hospital · Kim Kyung-hee · Oh Byung-hee